Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diode laser and photodynamic therapy versus ciclopirox HPCH nail lacquer for onychomycosis
2022-003913-12Phase 4Active
- Sponsor
- Complutense University of Madrid
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciclopirox in onychomycosis (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Primary efficacy outcome. Started Feb 2023; status: active.
02
Drugs
ciclopirox
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2022-003913-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003913-12.